Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukoplakia, Oral | 16 | 2024 | 73 | 6.220 |
Why?
|
Mouth Neoplasms | 23 | 2024 | 601 | 6.140 |
Why?
|
Mouth Diseases | 19 | 2020 | 239 | 5.300 |
Why?
|
Osteonecrosis | 20 | 2015 | 227 | 4.040 |
Why?
|
Mouth Mucosa | 22 | 2021 | 434 | 4.000 |
Why?
|
Keratosis | 7 | 2021 | 81 | 3.460 |
Why?
|
Jaw Diseases | 14 | 2020 | 90 | 3.440 |
Why?
|
Diphosphonates | 19 | 2016 | 625 | 3.320 |
Why?
|
Lichen Planus, Oral | 11 | 2023 | 53 | 2.770 |
Why?
|
Odontogenic Tumors | 7 | 2021 | 45 | 2.740 |
Why?
|
Precancerous Conditions | 11 | 2024 | 971 | 2.530 |
Why?
|
Oral Ulcer | 12 | 2021 | 96 | 2.390 |
Why?
|
Mandibular Diseases | 10 | 2016 | 119 | 2.360 |
Why?
|
Tongue | 6 | 2022 | 406 | 2.050 |
Why?
|
Mouth | 6 | 2020 | 373 | 1.890 |
Why?
|
Bone Density Conservation Agents | 12 | 2011 | 774 | 1.740 |
Why?
|
Tongue Diseases | 5 | 2021 | 67 | 1.680 |
Why?
|
Carcinoma, Squamous Cell | 14 | 2024 | 4029 | 1.190 |
Why?
|
Tongue Neoplasms | 5 | 2022 | 179 | 1.090 |
Why?
|
Palate, Hard | 5 | 2017 | 57 | 1.080 |
Why?
|
Gingival Diseases | 3 | 2021 | 34 | 1.060 |
Why?
|
Epstein-Barr Virus Infections | 4 | 2021 | 569 | 1.050 |
Why?
|
Jaw | 5 | 2017 | 96 | 1.010 |
Why?
|
Alveolar Process | 3 | 2020 | 293 | 1.000 |
Why?
|
Diagnosis, Differential | 37 | 2021 | 12958 | 0.980 |
Why?
|
Palatal Neoplasms | 4 | 2017 | 35 | 0.940 |
Why?
|
Stomatitis | 4 | 2021 | 269 | 0.920 |
Why?
|
Graft vs Host Disease | 15 | 2018 | 2951 | 0.920 |
Why?
|
Foreign-Body Reaction | 2 | 2014 | 157 | 0.900 |
Why?
|
Mandibular Neoplasms | 3 | 2020 | 129 | 0.880 |
Why?
|
Papillomavirus Infections | 4 | 2017 | 1585 | 0.870 |
Why?
|
CREST Syndrome | 1 | 2022 | 6 | 0.850 |
Why?
|
Carcinoma in Situ | 3 | 2021 | 802 | 0.840 |
Why?
|
Leukemia, Eosinophilic, Acute | 1 | 2021 | 5 | 0.830 |
Why?
|
Bronchogenic Cyst | 1 | 2021 | 29 | 0.790 |
Why?
|
Burning Mouth Syndrome | 4 | 2019 | 31 | 0.780 |
Why?
|
Salivary Gland Diseases | 2 | 2019 | 37 | 0.770 |
Why?
|
Lichenoid Eruptions | 1 | 2020 | 14 | 0.770 |
Why?
|
Herpes Labialis | 3 | 2010 | 29 | 0.750 |
Why?
|
Jaw Neoplasms | 3 | 2015 | 70 | 0.740 |
Why?
|
Diagnosis, Oral | 2 | 2014 | 23 | 0.740 |
Why?
|
Maxillary Neoplasms | 2 | 2020 | 45 | 0.720 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2019 | 69 | 0.710 |
Why?
|
Sarcoma, Synovial | 1 | 2020 | 164 | 0.670 |
Why?
|
Triamcinolone Acetonide | 3 | 2019 | 101 | 0.670 |
Why?
|
Immunosuppressive Agents | 6 | 2018 | 4147 | 0.660 |
Why?
|
Candidiasis, Oral | 2 | 2016 | 60 | 0.640 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 2 | 2019 | 123 | 0.640 |
Why?
|
Lip Neoplasms | 2 | 2011 | 37 | 0.630 |
Why?
|
Jaw Cysts | 2 | 2015 | 7 | 0.630 |
Why?
|
Middle Aged | 91 | 2024 | 213127 | 0.620 |
Why?
|
Humans | 183 | 2024 | 742088 | 0.610 |
Why?
|
Hyperplasia | 5 | 2022 | 1183 | 0.600 |
Why?
|
Salivary Ducts | 1 | 2017 | 24 | 0.600 |
Why?
|
Leukoplakia | 3 | 2020 | 18 | 0.600 |
Why?
|
Xerostomia | 3 | 2020 | 95 | 0.590 |
Why?
|
Female | 114 | 2024 | 379592 | 0.590 |
Why?
|
Lipoma | 2 | 2018 | 334 | 0.590 |
Why?
|
Aged | 75 | 2022 | 162944 | 0.590 |
Why?
|
Hematopoietic Stem Cell Transplantation | 12 | 2018 | 5425 | 0.580 |
Why?
|
Male | 105 | 2024 | 349538 | 0.580 |
Why?
|
Erythema | 1 | 2018 | 254 | 0.570 |
Why?
|
Lymphoproliferative Disorders | 3 | 2013 | 525 | 0.560 |
Why?
|
Pemphigoid, Bullous | 2 | 2019 | 108 | 0.560 |
Why?
|
Aged, 80 and over | 38 | 2021 | 57683 | 0.540 |
Why?
|
Biopsy | 11 | 2021 | 6756 | 0.540 |
Why?
|
Leukoplakia, Hairy | 3 | 2021 | 8 | 0.540 |
Why?
|
Dental Care | 2 | 2019 | 262 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 380 | 0.530 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2940 | 0.520 |
Why?
|
Gingivitis | 3 | 2019 | 124 | 0.500 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 535 | 0.500 |
Why?
|
Adult | 68 | 2021 | 213712 | 0.480 |
Why?
|
Imidazoles | 4 | 2016 | 1205 | 0.460 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2015 | 234 | 0.460 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2013 | 76 | 0.460 |
Why?
|
Sialometaplasia, Necrotizing | 2 | 2012 | 6 | 0.450 |
Why?
|
Neurofibroma | 1 | 2013 | 106 | 0.450 |
Why?
|
Oral Medicine | 3 | 2023 | 31 | 0.440 |
Why?
|
Sublingual Gland Neoplasms | 1 | 2012 | 2 | 0.440 |
Why?
|
Granulomatosis, Orofacial | 1 | 2012 | 2 | 0.440 |
Why?
|
Epistaxis | 1 | 2013 | 111 | 0.430 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2013 | 67 | 0.430 |
Why?
|
Immunocompromised Host | 2 | 2016 | 847 | 0.430 |
Why?
|
Glucocorticoids | 5 | 2019 | 2107 | 0.430 |
Why?
|
Carrier State | 1 | 2016 | 518 | 0.430 |
Why?
|
Durapatite | 1 | 2013 | 161 | 0.430 |
Why?
|
Membranes, Artificial | 1 | 2014 | 378 | 0.430 |
Why?
|
Bronchiectasis | 1 | 2013 | 128 | 0.420 |
Why?
|
Craniofacial Abnormalities | 2 | 2014 | 315 | 0.410 |
Why?
|
Intubation | 1 | 2012 | 141 | 0.410 |
Why?
|
Skull Base Neoplasms | 1 | 2015 | 284 | 0.410 |
Why?
|
Absorbable Implants | 1 | 2014 | 342 | 0.410 |
Why?
|
Cysts | 1 | 2017 | 676 | 0.400 |
Why?
|
Antineoplastic Agents | 6 | 2017 | 13655 | 0.400 |
Why?
|
Foreign-Body Migration | 1 | 2013 | 221 | 0.400 |
Why?
|
Pigmentation Disorders | 1 | 2011 | 101 | 0.390 |
Why?
|
Xanthomatosis | 1 | 2011 | 32 | 0.390 |
Why?
|
Bone Marrow | 1 | 2021 | 2941 | 0.390 |
Why?
|
Fibroma | 2 | 2017 | 212 | 0.390 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2013 | 153 | 0.390 |
Why?
|
Hyperpigmentation | 2 | 2020 | 112 | 0.380 |
Why?
|
Mouth Rehabilitation | 1 | 2010 | 11 | 0.380 |
Why?
|
Salivary Glands, Minor | 2 | 2013 | 27 | 0.380 |
Why?
|
Bacteremia | 2 | 2017 | 962 | 0.380 |
Why?
|
Respiratory Mucosa | 1 | 2014 | 427 | 0.380 |
Why?
|
Dental Caries | 3 | 2012 | 415 | 0.380 |
Why?
|
Tooth Abnormalities | 1 | 2010 | 54 | 0.370 |
Why?
|
Fatty Alcohols | 1 | 2010 | 23 | 0.370 |
Why?
|
Tumor Virus Infections | 1 | 2013 | 451 | 0.370 |
Why?
|
Alphapapillomavirus | 1 | 2013 | 221 | 0.370 |
Why?
|
Papillomaviridae | 2 | 2014 | 1118 | 0.370 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 316 | 0.370 |
Why?
|
Maxillary Diseases | 2 | 2010 | 51 | 0.360 |
Why?
|
Melanosis | 2 | 2008 | 78 | 0.360 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2014 | 395 | 0.360 |
Why?
|
Transplantation Conditioning | 3 | 2017 | 1597 | 0.360 |
Why?
|
Granuloma | 1 | 2012 | 315 | 0.360 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2130 | 0.350 |
Why?
|
Nose | 1 | 2013 | 509 | 0.350 |
Why?
|
Dental Fistula | 1 | 2009 | 13 | 0.350 |
Why?
|
Automatism | 1 | 2009 | 9 | 0.350 |
Why?
|
Radiography, Panoramic | 3 | 2015 | 115 | 0.340 |
Why?
|
Dwarfism | 1 | 2010 | 145 | 0.340 |
Why?
|
Streptococcal Infections | 1 | 2014 | 637 | 0.340 |
Why?
|
Coagulation Protein Disorders | 1 | 2008 | 7 | 0.340 |
Why?
|
Lip Diseases | 2 | 2012 | 18 | 0.340 |
Why?
|
Granular Cell Tumor | 2 | 2014 | 51 | 0.340 |
Why?
|
Quinacrine | 1 | 2008 | 24 | 0.340 |
Why?
|
Plasminogen | 1 | 2008 | 152 | 0.330 |
Why?
|
Collagen | 2 | 2014 | 2684 | 0.330 |
Why?
|
Mouthwashes | 4 | 2021 | 59 | 0.320 |
Why?
|
Neurodermatitis | 1 | 2008 | 8 | 0.320 |
Why?
|
Solitary Fibrous Tumors | 1 | 2009 | 72 | 0.320 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2008 | 50 | 0.320 |
Why?
|
Lactic Acid | 1 | 2013 | 1132 | 0.320 |
Why?
|
Biological Factors | 2 | 2019 | 164 | 0.310 |
Why?
|
Hyaluronic Acid | 1 | 2011 | 489 | 0.310 |
Why?
|
Paresthesia | 2 | 2020 | 162 | 0.310 |
Why?
|
Retrospective Studies | 35 | 2022 | 77098 | 0.300 |
Why?
|
Adolescent | 32 | 2021 | 85649 | 0.300 |
Why?
|
Keratinocytes | 4 | 2021 | 797 | 0.300 |
Why?
|
Administration, Topical | 5 | 2018 | 688 | 0.300 |
Why?
|
Clonazepam | 2 | 2017 | 136 | 0.300 |
Why?
|
Antiviral Agents | 4 | 2014 | 2978 | 0.290 |
Why?
|
Bone Neoplasms | 3 | 2015 | 2522 | 0.290 |
Why?
|
Odontogenic Cysts | 2 | 2020 | 41 | 0.290 |
Why?
|
Polymers | 1 | 2013 | 1618 | 0.280 |
Why?
|
Acyclovir | 1 | 2007 | 272 | 0.280 |
Why?
|
Heart Valves | 1 | 2008 | 291 | 0.280 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2010 | 448 | 0.270 |
Why?
|
Polyps | 1 | 2007 | 189 | 0.270 |
Why?
|
Republic of Korea | 9 | 2020 | 538 | 0.270 |
Why?
|
Salivary Glands | 3 | 2019 | 228 | 0.260 |
Why?
|
Herpesvirus 4, Human | 4 | 2021 | 1040 | 0.260 |
Why?
|
Pain Measurement | 3 | 2012 | 3418 | 0.260 |
Why?
|
Young Adult | 24 | 2021 | 56350 | 0.260 |
Why?
|
Valine | 1 | 2007 | 413 | 0.260 |
Why?
|
Biocompatible Materials | 1 | 2013 | 1731 | 0.250 |
Why?
|
Adenoma, Pleomorphic | 1 | 2005 | 75 | 0.250 |
Why?
|
Periodontal Diseases | 1 | 2008 | 449 | 0.240 |
Why?
|
Dyskeratosis Congenita | 1 | 2004 | 72 | 0.240 |
Why?
|
Parotid Neoplasms | 1 | 2005 | 155 | 0.240 |
Why?
|
Endocarditis, Bacterial | 1 | 2008 | 453 | 0.230 |
Why?
|
Osteoradionecrosis | 2 | 2017 | 49 | 0.230 |
Why?
|
Minocycline | 1 | 2004 | 163 | 0.220 |
Why?
|
Adenoma | 2 | 2011 | 2168 | 0.220 |
Why?
|
Dendritic Cells | 1 | 2013 | 2723 | 0.210 |
Why?
|
Gingival Neoplasms | 2 | 2019 | 21 | 0.210 |
Why?
|
Radiography | 10 | 2018 | 7010 | 0.200 |
Why?
|
Salivary Gland Neoplasms | 1 | 2005 | 297 | 0.200 |
Why?
|
Stomatitis, Herpetic | 2 | 2014 | 12 | 0.200 |
Why?
|
Tooth, Impacted | 2 | 2015 | 42 | 0.200 |
Why?
|
Prevalence | 12 | 2017 | 15194 | 0.200 |
Why?
|
Prednisone | 4 | 2014 | 1567 | 0.200 |
Why?
|
Antimalarials | 1 | 2008 | 903 | 0.200 |
Why?
|
Chewing Gum | 1 | 2021 | 41 | 0.200 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 694 | 0.200 |
Why?
|
Pathology, Oral | 1 | 2021 | 6 | 0.200 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2013 | 704 | 0.200 |
Why?
|
Piperazines | 1 | 2011 | 2488 | 0.190 |
Why?
|
Mandible | 2 | 2021 | 740 | 0.190 |
Why?
|
Immunohistochemistry | 8 | 2018 | 11363 | 0.190 |
Why?
|
Sarcoma, Myeloid | 1 | 2021 | 59 | 0.190 |
Why?
|
Periapical Diseases | 2 | 2012 | 26 | 0.190 |
Why?
|
Lymphocytosis | 1 | 2021 | 119 | 0.180 |
Why?
|
Anti-Ulcer Agents | 1 | 2021 | 119 | 0.180 |
Why?
|
Health Care Costs | 1 | 2014 | 3203 | 0.180 |
Why?
|
Tobacco, Smokeless | 1 | 2021 | 129 | 0.180 |
Why?
|
Tooth Extraction | 3 | 2011 | 222 | 0.180 |
Why?
|
Warfarin | 1 | 2008 | 1493 | 0.180 |
Why?
|
Child | 18 | 2021 | 77478 | 0.180 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2020 | 85 | 0.180 |
Why?
|
Pyrimidines | 1 | 2011 | 2933 | 0.180 |
Why?
|
Head and Neck Neoplasms | 3 | 2019 | 2712 | 0.170 |
Why?
|
Hearing Loss | 2 | 2017 | 765 | 0.170 |
Why?
|
Heart Valve Prosthesis | 1 | 2008 | 1486 | 0.170 |
Why?
|
Dexamethasone | 2 | 2018 | 1949 | 0.170 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 768 | 0.160 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 2536 | 0.160 |
Why?
|
Algorithms | 2 | 2016 | 13853 | 0.160 |
Why?
|
Adipocytes | 1 | 2005 | 1182 | 0.160 |
Why?
|
False Negative Reactions | 1 | 2019 | 587 | 0.160 |
Why?
|
Pemphigus | 1 | 2019 | 103 | 0.160 |
Why?
|
Lung | 2 | 2013 | 9826 | 0.160 |
Why?
|
Otoscopy | 1 | 2017 | 36 | 0.150 |
Why?
|
Severity of Illness Index | 6 | 2013 | 15530 | 0.150 |
Why?
|
Sjogren's Syndrome | 1 | 2019 | 229 | 0.150 |
Why?
|
Anti-Inflammatory Agents | 2 | 2019 | 1788 | 0.150 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2008 | 1527 | 0.150 |
Why?
|
Eosinophilia | 1 | 2021 | 531 | 0.150 |
Why?
|
Atrophy | 1 | 2022 | 1576 | 0.150 |
Why?
|
Gingival Hyperplasia | 2 | 2015 | 17 | 0.150 |
Why?
|
Injections, Intralesional | 2 | 2019 | 276 | 0.150 |
Why?
|
Necrosis | 1 | 2021 | 1643 | 0.140 |
Why?
|
Alendronate | 2 | 2010 | 171 | 0.140 |
Why?
|
5-Methylcytosine | 1 | 2017 | 153 | 0.140 |
Why?
|
Tacrolimus | 2 | 2018 | 741 | 0.140 |
Why?
|
Otitis Media, Suppurative | 1 | 2016 | 26 | 0.140 |
Why?
|
Antigens, CD | 2 | 2018 | 4024 | 0.140 |
Why?
|
Epithelium | 1 | 2021 | 1680 | 0.140 |
Why?
|
Cementoma | 1 | 2015 | 4 | 0.140 |
Why?
|
DNA, Neoplasm | 1 | 2021 | 1758 | 0.140 |
Why?
|
Semaphorins | 1 | 2016 | 101 | 0.140 |
Why?
|
Dental Cementum | 1 | 2015 | 52 | 0.140 |
Why?
|
Sodium Tetradecyl Sulfate | 1 | 2015 | 14 | 0.140 |
Why?
|
Hyperbaric Oxygenation | 1 | 2017 | 163 | 0.140 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2107 | 0.140 |
Why?
|
Injections, Intravenous | 2 | 2008 | 1420 | 0.140 |
Why?
|
Odontogenesis | 1 | 2015 | 66 | 0.130 |
Why?
|
Ossicular Replacement | 1 | 2015 | 12 | 0.130 |
Why?
|
Personal Satisfaction | 1 | 2020 | 634 | 0.130 |
Why?
|
Treatment Outcome | 16 | 2023 | 62966 | 0.130 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4187 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2016 | 39004 | 0.130 |
Why?
|
Neck Dissection | 1 | 2017 | 196 | 0.130 |
Why?
|
Periodontium | 1 | 2015 | 99 | 0.130 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2015 | 54 | 0.130 |
Why?
|
Postoperative Complications | 3 | 2014 | 15244 | 0.130 |
Why?
|
Bone Matrix | 1 | 2015 | 118 | 0.130 |
Why?
|
Multivariate Analysis | 8 | 2017 | 12242 | 0.130 |
Why?
|
Human papillomavirus 16 | 1 | 2017 | 262 | 0.130 |
Why?
|
Risk Factors | 19 | 2021 | 72145 | 0.130 |
Why?
|
Oral Health | 2 | 2019 | 472 | 0.130 |
Why?
|
Hearing Loss, Unilateral | 1 | 2015 | 26 | 0.130 |
Why?
|
Tympanoplasty | 1 | 2015 | 71 | 0.130 |
Why?
|
Fibroma, Ossifying | 1 | 2015 | 19 | 0.130 |
Why?
|
Edema | 1 | 2019 | 790 | 0.130 |
Why?
|
Liposarcoma | 1 | 2018 | 333 | 0.130 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2022 | 1820 | 0.130 |
Why?
|
Drug Compounding | 1 | 2016 | 242 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 3 | 2013 | 1847 | 0.130 |
Why?
|
Ear | 1 | 2015 | 173 | 0.120 |
Why?
|
Dementia, Vascular | 1 | 2015 | 127 | 0.120 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1377 | 0.120 |
Why?
|
Sclerotherapy | 1 | 2015 | 175 | 0.120 |
Why?
|
Collateral Circulation | 1 | 2015 | 287 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3564 | 0.120 |
Why?
|
Cheilitis | 1 | 2013 | 8 | 0.120 |
Why?
|
Hearing Loss, Conductive | 1 | 2015 | 158 | 0.120 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2638 | 0.120 |
Why?
|
Ear, External | 1 | 2014 | 160 | 0.120 |
Why?
|
Fibroblasts | 2 | 2015 | 4143 | 0.120 |
Why?
|
Lichen Sclerosus et Atrophicus | 1 | 2014 | 28 | 0.120 |
Why?
|
Neoplasms | 6 | 2021 | 21596 | 0.120 |
Why?
|
Injections, Intradermal | 1 | 2013 | 117 | 0.120 |
Why?
|
Maxilla | 1 | 2016 | 469 | 0.120 |
Why?
|
Osteotomy, Le Fort | 1 | 2014 | 88 | 0.120 |
Why?
|
Mycobacterium avium Complex | 1 | 2013 | 60 | 0.120 |
Why?
|
Hearing | 1 | 2017 | 479 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2021 | 3497 | 0.110 |
Why?
|
Ethambutol | 1 | 2013 | 60 | 0.110 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2014 | 194 | 0.110 |
Why?
|
Gene Silencing | 1 | 2020 | 1538 | 0.110 |
Why?
|
Anticoagulants | 1 | 2008 | 4595 | 0.110 |
Why?
|
Clarithromycin | 1 | 2013 | 86 | 0.110 |
Why?
|
Ear Diseases | 1 | 2014 | 169 | 0.110 |
Why?
|
Refugees | 1 | 2020 | 510 | 0.110 |
Why?
|
Furcation Defects | 1 | 2013 | 36 | 0.110 |
Why?
|
Chest Wall Oscillation | 1 | 2012 | 12 | 0.110 |
Why?
|
Dizziness | 1 | 2015 | 250 | 0.110 |
Why?
|
Vestibular Diseases | 1 | 2015 | 217 | 0.110 |
Why?
|
Genomics | 2 | 2019 | 5692 | 0.110 |
Why?
|
Sex Factors | 4 | 2017 | 10392 | 0.110 |
Why?
|
Anti-Bacterial Agents | 3 | 2013 | 7153 | 0.110 |
Why?
|
Stomatitis, Aphthous | 1 | 2013 | 51 | 0.110 |
Why?
|
Child, Preschool | 9 | 2017 | 40955 | 0.110 |
Why?
|
Lung Volume Measurements | 1 | 2013 | 377 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1581 | 0.110 |
Why?
|
Thymus Neoplasms | 1 | 2014 | 268 | 0.100 |
Why?
|
Oncology Service, Hospital | 1 | 2012 | 57 | 0.100 |
Why?
|
Osteomyelitis | 1 | 2016 | 402 | 0.100 |
Why?
|
Azithromycin | 1 | 2013 | 195 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 20086 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3585 | 0.100 |
Why?
|
Viscosupplements | 1 | 2011 | 23 | 0.100 |
Why?
|
Polyesters | 1 | 2013 | 363 | 0.100 |
Why?
|
Chronic Disease | 7 | 2016 | 9144 | 0.100 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2885 | 0.100 |
Why?
|
Boston | 4 | 2019 | 9305 | 0.100 |
Why?
|
Tinnitus | 1 | 2014 | 195 | 0.100 |
Why?
|
Myxoma | 1 | 2012 | 130 | 0.100 |
Why?
|
Rifampin | 1 | 2013 | 315 | 0.100 |
Why?
|
Cytomegalovirus Infections | 2 | 2008 | 817 | 0.100 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2014 | 414 | 0.100 |
Why?
|
Gingiva | 1 | 2013 | 388 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3328 | 0.100 |
Why?
|
Foam Cells | 1 | 2011 | 71 | 0.100 |
Why?
|
Immunotherapy | 2 | 2024 | 4414 | 0.100 |
Why?
|
Root Resorption | 1 | 2010 | 42 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 545 | 0.090 |
Why?
|
Oroantral Fistula | 1 | 2010 | 8 | 0.090 |
Why?
|
Dry Socket | 1 | 2010 | 7 | 0.090 |
Why?
|
Radiography, Dental, Digital | 1 | 2010 | 12 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2011 | 126 | 0.090 |
Why?
|
Amyloid | 1 | 2015 | 795 | 0.090 |
Why?
|
Rhinoplasty | 1 | 2014 | 226 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2014 | 435 | 0.090 |
Why?
|
Micrognathism | 1 | 2010 | 57 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 484 | 0.090 |
Why?
|
Menisci, Tibial | 1 | 2013 | 269 | 0.090 |
Why?
|
Congenital Abnormalities | 1 | 2015 | 707 | 0.090 |
Why?
|
Osteosclerosis | 1 | 2010 | 39 | 0.090 |
Why?
|
Lip | 1 | 2012 | 195 | 0.090 |
Why?
|
Facies | 1 | 2010 | 197 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2015 | 450 | 0.090 |
Why?
|
Lidocaine | 1 | 2013 | 542 | 0.090 |
Why?
|
Pain | 2 | 2023 | 4961 | 0.090 |
Why?
|
Adenocarcinoma | 2 | 2019 | 6347 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1351 | 0.090 |
Why?
|
Cosmetic Techniques | 1 | 2011 | 135 | 0.090 |
Why?
|
Amyloidosis | 1 | 2016 | 795 | 0.090 |
Why?
|
Hypertrophy | 1 | 2011 | 568 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2948 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2019 | 1335 | 0.090 |
Why?
|
Bites, Human | 1 | 2009 | 10 | 0.090 |
Why?
|
Uterine Cervicitis | 1 | 2008 | 30 | 0.080 |
Why?
|
Immunologic Factors | 2 | 2021 | 1575 | 0.080 |
Why?
|
Vasculitis | 1 | 2013 | 521 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 3020 | 0.080 |
Why?
|
Friction | 1 | 2009 | 59 | 0.080 |
Why?
|
Nonprescription Drugs | 1 | 2010 | 116 | 0.080 |
Why?
|
Tooth Socket | 1 | 2010 | 124 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1905 | 0.080 |
Why?
|
Heart Transplantation | 1 | 2002 | 3119 | 0.080 |
Why?
|
Health Surveys | 2 | 2016 | 4030 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2585 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9185 | 0.080 |
Why?
|
Periodontal Pocket | 1 | 2009 | 166 | 0.080 |
Why?
|
Protein Kinases | 1 | 2016 | 1638 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2015 | 795 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2013 | 4029 | 0.080 |
Why?
|
Dental Care for Chronically Ill | 1 | 2008 | 33 | 0.080 |
Why?
|
Habits | 1 | 2009 | 137 | 0.080 |
Why?
|
Saliva | 2 | 2019 | 805 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4438 | 0.080 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2008 | 88 | 0.080 |
Why?
|
Prognosis | 7 | 2020 | 29010 | 0.080 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2008 | 55 | 0.080 |
Why?
|
Survivors | 1 | 2018 | 2286 | 0.080 |
Why?
|
Accidental Falls | 1 | 2015 | 1057 | 0.080 |
Why?
|
Trigeminal Ganglion | 1 | 2008 | 186 | 0.080 |
Why?
|
Korea | 3 | 2012 | 99 | 0.080 |
Why?
|
Trachea | 1 | 2013 | 1075 | 0.080 |
Why?
|
Age Distribution | 2 | 2014 | 2900 | 0.070 |
Why?
|
Lymphocytes | 1 | 2015 | 2614 | 0.070 |
Why?
|
Erythema Multiforme | 1 | 2007 | 31 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1562 | 0.070 |
Why?
|
Immunoenzyme Techniques | 2 | 2017 | 1799 | 0.070 |
Why?
|
Observer Variation | 3 | 2013 | 2593 | 0.070 |
Why?
|
Staphylococcus aureus | 1 | 2015 | 1449 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2009 | 657 | 0.070 |
Why?
|
Recurrence | 3 | 2021 | 8333 | 0.070 |
Why?
|
Syndrome | 2 | 2010 | 3248 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 689 | 0.070 |
Why?
|
Drinking | 1 | 2008 | 197 | 0.070 |
Why?
|
Prospective Studies | 8 | 2019 | 53187 | 0.070 |
Why?
|
Phenotype | 2 | 2021 | 16331 | 0.070 |
Why?
|
Bell Palsy | 1 | 2007 | 42 | 0.070 |
Why?
|
Neoplasm Staging | 3 | 2017 | 11001 | 0.070 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2014 | 1101 | 0.070 |
Why?
|
Bone Marrow Transplantation | 2 | 2005 | 2763 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2013 | 957 | 0.070 |
Why?
|
Inflammation | 3 | 2015 | 10578 | 0.070 |
Why?
|
Clindamycin | 1 | 2006 | 139 | 0.070 |
Why?
|
Sunscreening Agents | 1 | 2007 | 132 | 0.070 |
Why?
|
Societies, Dental | 1 | 2005 | 33 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.070 |
Why?
|
Benzamides | 1 | 2011 | 1378 | 0.070 |
Why?
|
Osteosarcoma | 1 | 2012 | 880 | 0.070 |
Why?
|
Anesthetics, Local | 1 | 2013 | 984 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1889 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2015 | 1327 | 0.070 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1869 | 0.070 |
Why?
|
Cohort Studies | 7 | 2019 | 40450 | 0.070 |
Why?
|
Photography, Dental | 1 | 2005 | 21 | 0.070 |
Why?
|
Cytosine | 1 | 2007 | 216 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.070 |
Why?
|
Pneumonectomy | 1 | 2012 | 1093 | 0.070 |
Why?
|
Mesenchymoma | 1 | 2005 | 47 | 0.070 |
Why?
|
Multiple Myeloma | 3 | 2008 | 5169 | 0.070 |
Why?
|
Secretory Rate | 1 | 2005 | 82 | 0.070 |
Why?
|
Xerophthalmia | 1 | 2005 | 18 | 0.070 |
Why?
|
Chlorhexidine | 1 | 2006 | 162 | 0.070 |
Why?
|
Nutritional Status | 1 | 2014 | 1606 | 0.060 |
Why?
|
Technology Transfer | 1 | 2005 | 44 | 0.060 |
Why?
|
Incidence | 4 | 2016 | 20928 | 0.060 |
Why?
|
Shock, Septic | 1 | 2012 | 773 | 0.060 |
Why?
|
Cerebral Hemorrhage | 1 | 2016 | 2643 | 0.060 |
Why?
|
Quality of Life | 7 | 2020 | 12730 | 0.060 |
Why?
|
Proportional Hazards Models | 3 | 2014 | 12344 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3070 | 0.060 |
Why?
|
Age Factors | 3 | 2017 | 18355 | 0.060 |
Why?
|
Metaplasia | 1 | 2005 | 313 | 0.060 |
Why?
|
Laryngoscopy | 1 | 2010 | 706 | 0.060 |
Why?
|
Congresses as Topic | 2 | 2019 | 764 | 0.060 |
Why?
|
Lung Diseases | 1 | 2014 | 1884 | 0.060 |
Why?
|
Wound Healing | 3 | 2011 | 2781 | 0.060 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1379 | 0.060 |
Why?
|
Noise | 2 | 2017 | 279 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2015 | 11472 | 0.060 |
Why?
|
Comorbidity | 3 | 2017 | 10372 | 0.060 |
Why?
|
Homozygote | 1 | 2008 | 1777 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2015 | 2706 | 0.060 |
Why?
|
Survival Rate | 5 | 2021 | 12773 | 0.060 |
Why?
|
Carcinoma | 1 | 2015 | 2374 | 0.060 |
Why?
|
Drug Approval | 1 | 2010 | 740 | 0.060 |
Why?
|
Self-Injurious Behavior | 1 | 2009 | 462 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1769 | 0.060 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2005 | 221 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2019 | 5705 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6483 | 0.060 |
Why?
|
Postoperative Period | 1 | 2008 | 1839 | 0.050 |
Why?
|
Hemorrhage | 1 | 2015 | 3461 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2015 | 3748 | 0.050 |
Why?
|
Laparoscopy | 1 | 2014 | 2121 | 0.050 |
Why?
|
S100 Proteins | 1 | 2003 | 259 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2007 | 1849 | 0.050 |
Why?
|
Amyloid beta-Peptides | 1 | 2015 | 3574 | 0.050 |
Why?
|
Anemia, Aplastic | 1 | 2004 | 226 | 0.050 |
Why?
|
Muromonab-CD3 | 1 | 2002 | 96 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15056 | 0.050 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2005 | 246 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9941 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1668 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10163 | 0.050 |
Why?
|
Cross-Sectional Studies | 6 | 2020 | 24913 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2008 | 921 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3381 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2010 | 1581 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1434 | 0.050 |
Why?
|
Cranial Irradiation | 1 | 2005 | 401 | 0.050 |
Why?
|
Intubation, Intratracheal | 1 | 2010 | 1357 | 0.050 |
Why?
|
Crohn Disease | 1 | 2015 | 2301 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6534 | 0.050 |
Why?
|
Animals | 8 | 2020 | 168561 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2015 | 3527 | 0.050 |
Why?
|
Image Enhancement | 1 | 2013 | 2921 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2006 | 598 | 0.050 |
Why?
|
Hospital Mortality | 2 | 2012 | 5310 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2008 | 930 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2015 | 4030 | 0.050 |
Why?
|
Democratic People's Republic of Korea | 1 | 2020 | 12 | 0.050 |
Why?
|
Massachusetts | 1 | 2014 | 8662 | 0.050 |
Why?
|
Steroids | 1 | 2006 | 931 | 0.050 |
Why?
|
Mucocele | 2 | 2012 | 49 | 0.050 |
Why?
|
Early Diagnosis | 2 | 2017 | 1184 | 0.050 |
Why?
|
Disease Progression | 2 | 2016 | 13256 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3691 | 0.050 |
Why?
|
Medical Oncology | 1 | 2012 | 2235 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2007 | 1520 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2021 | 7988 | 0.050 |
Why?
|
Mastectomy | 1 | 2008 | 1789 | 0.050 |
Why?
|
Specimen Handling | 1 | 2005 | 692 | 0.050 |
Why?
|
Logistic Models | 4 | 2017 | 13403 | 0.050 |
Why?
|
Heart Valve Diseases | 1 | 2008 | 1067 | 0.040 |
Why?
|
Delphi Technique | 1 | 2023 | 778 | 0.040 |
Why?
|
Drug Resistance | 1 | 2006 | 1608 | 0.040 |
Why?
|
Time Factors | 6 | 2014 | 40054 | 0.040 |
Why?
|
Community Medicine | 1 | 2019 | 25 | 0.040 |
Why?
|
Critical Illness | 1 | 2012 | 2665 | 0.040 |
Why?
|
Pilot Projects | 2 | 2019 | 8297 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2006 | 971 | 0.040 |
Why?
|
Nutrition Surveys | 2 | 2017 | 1656 | 0.040 |
Why?
|
Brain | 2 | 2016 | 26343 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2022 | 588 | 0.040 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2002 | 265 | 0.040 |
Why?
|
Lung Transplantation | 1 | 2007 | 1155 | 0.040 |
Why?
|
Lasers | 1 | 2023 | 952 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2012 | 3679 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3038 | 0.040 |
Why?
|
Loneliness | 1 | 2020 | 184 | 0.040 |
Why?
|
Mutation | 2 | 2020 | 29717 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2013 | 19862 | 0.040 |
Why?
|
Personal Autonomy | 1 | 2020 | 297 | 0.040 |
Why?
|
United States | 4 | 2015 | 69693 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2014 | 6891 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9410 | 0.040 |
Why?
|
Dentists | 1 | 2019 | 169 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2016 | 35342 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 1599 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2023 | 1969 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2008 | 2002 | 0.040 |
Why?
|
ROC Curve | 2 | 2015 | 3528 | 0.040 |
Why?
|
Audiometry | 1 | 2017 | 242 | 0.040 |
Why?
|
Solutions | 1 | 2017 | 426 | 0.040 |
Why?
|
Aging | 1 | 2015 | 8626 | 0.040 |
Why?
|
Bone and Bones | 1 | 2007 | 2575 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1423 | 0.030 |
Why?
|
Osteoporosis | 1 | 2005 | 1581 | 0.030 |
Why?
|
Sclerosing Solutions | 1 | 2015 | 78 | 0.030 |
Why?
|
Societies, Medical | 1 | 2007 | 3740 | 0.030 |
Why?
|
Odontogenic Cyst, Calcifying | 1 | 2015 | 6 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2008 | 3187 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2011 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2013 | 2372 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2016 | 9274 | 0.030 |
Why?
|
Tympanic Membrane Perforation | 1 | 2014 | 41 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2019 | 729 | 0.030 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2014 | 49 | 0.030 |
Why?
|
Nevus | 1 | 2016 | 204 | 0.030 |
Why?
|
Hearing Tests | 1 | 2015 | 122 | 0.030 |
Why?
|
Administration, Oral | 2 | 2016 | 3913 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2015 | 204 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2016 | 341 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2014 | 4771 | 0.030 |
Why?
|
Skin Neoplasms | 2 | 2004 | 5662 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3266 | 0.030 |
Why?
|
Petrolatum | 1 | 2013 | 8 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2014 | 20774 | 0.030 |
Why?
|
Photomicrography | 1 | 2013 | 74 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2017 | 670 | 0.030 |
Why?
|
Keratolytic Agents | 1 | 2013 | 31 | 0.030 |
Why?
|
Emollients | 1 | 2013 | 33 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10232 | 0.030 |
Why?
|
Immunomodulation | 1 | 2018 | 540 | 0.030 |
Why?
|
Immunoblotting | 1 | 2017 | 1683 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5171 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2015 | 364 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2935 | 0.030 |
Why?
|
Mupirocin | 1 | 2013 | 56 | 0.030 |
Why?
|
Otitis Media with Effusion | 1 | 2014 | 114 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15108 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10248 | 0.030 |
Why?
|
Periodontal Cyst | 1 | 2013 | 4 | 0.030 |
Why?
|
Keloid | 1 | 2013 | 50 | 0.030 |
Why?
|
Acute Disease | 2 | 2014 | 7141 | 0.030 |
Why?
|
Endoscopy | 1 | 2023 | 1774 | 0.030 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2012 | 74 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2014 | 424 | 0.030 |
Why?
|
Stroke | 1 | 2015 | 9963 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2008 | 4246 | 0.030 |
Why?
|
Nomograms | 1 | 2014 | 224 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3612 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9846 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1983 | 0.030 |
Why?
|
Color | 1 | 2013 | 306 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14720 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1255 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2014 | 644 | 0.030 |
Why?
|
Keratins | 1 | 2013 | 515 | 0.030 |
Why?
|
Respiratory Therapy | 1 | 2012 | 132 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2016 | 983 | 0.030 |
Why?
|
Esthetics, Dental | 1 | 2013 | 250 | 0.030 |
Why?
|
Vincristine | 1 | 2014 | 1036 | 0.030 |
Why?
|
Memory | 1 | 2021 | 2163 | 0.020 |
Why?
|
Cytoplasm | 1 | 2016 | 1539 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1653 | 0.020 |
Why?
|
Postural Balance | 1 | 2015 | 620 | 0.020 |
Why?
|
Tretinoin | 1 | 2013 | 516 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2016 | 1438 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2012 | 381 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2014 | 723 | 0.020 |
Why?
|
Photography | 1 | 2013 | 521 | 0.020 |
Why?
|
Dermatologic Agents | 1 | 2013 | 274 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2016 | 13921 | 0.020 |
Why?
|
Chest Tubes | 1 | 2010 | 150 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2014 | 1097 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2533 | 0.020 |
Why?
|
Herpes Simplex | 1 | 2013 | 466 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2295 | 0.020 |
Why?
|
Thiazoles | 1 | 2016 | 1484 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 12695 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1350 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2021 | 3957 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1589 | 0.020 |
Why?
|
Physical Examination | 1 | 2014 | 1239 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1440 | 0.020 |
Why?
|
Income | 1 | 2017 | 1904 | 0.020 |
Why?
|
Organ Size | 1 | 2013 | 2253 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2014 | 742 | 0.020 |
Why?
|
Patient Compliance | 1 | 2019 | 2680 | 0.020 |
Why?
|
Drug Costs | 1 | 2016 | 1104 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1613 | 0.020 |
Why?
|
Granuloma, Pyogenic | 1 | 2008 | 48 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13019 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18006 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2236 | 0.020 |
Why?
|
Root Canal Therapy | 1 | 2008 | 65 | 0.020 |
Why?
|
Americas | 1 | 2007 | 111 | 0.020 |
Why?
|
Palate | 1 | 2008 | 123 | 0.020 |
Why?
|
Cicatrix | 1 | 2013 | 761 | 0.020 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 250 | 0.020 |
Why?
|
Ganciclovir | 1 | 2008 | 259 | 0.020 |
Why?
|
Cattle | 1 | 2013 | 3923 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2906 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2012 | 786 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2012 | 659 | 0.020 |
Why?
|
Doxorubicin | 1 | 2014 | 2215 | 0.020 |
Why?
|
Malnutrition | 1 | 2014 | 625 | 0.020 |
Why?
|
Trigeminal Neuralgia | 1 | 2008 | 113 | 0.020 |
Why?
|
Perioperative Care | 1 | 2014 | 997 | 0.020 |
Why?
|
Actuarial Analysis | 1 | 2007 | 377 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2017 | 1794 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 5979 | 0.020 |
Why?
|
Positron-Emission Tomography | 2 | 2016 | 6259 | 0.020 |
Why?
|
Arteries | 1 | 2012 | 1118 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2012 | 968 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7770 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2658 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2970 | 0.020 |
Why?
|
Mental Health | 1 | 2020 | 2997 | 0.020 |
Why?
|
Minerals | 1 | 2007 | 275 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2186 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19223 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.020 |
Why?
|
Postoperative Care | 1 | 2012 | 1484 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6030 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2015 | 2732 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2009 | 603 | 0.020 |
Why?
|
Collagen Type I | 1 | 2008 | 592 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2008 | 215 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2008 | 2027 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8425 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2008 | 575 | 0.020 |
Why?
|
RNA, Viral | 1 | 2013 | 2899 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 6722 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2736 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6974 | 0.010 |
Why?
|
Calcinosis | 1 | 2012 | 1497 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2013 | 1877 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5655 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4282 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2008 | 638 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1820 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14554 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2013 | 3678 | 0.010 |
Why?
|
Disease Management | 1 | 2012 | 2450 | 0.010 |
Why?
|
Osteogenesis | 1 | 2008 | 1299 | 0.010 |
Why?
|
Radiotherapy | 1 | 2008 | 1525 | 0.010 |
Why?
|
Smoking | 1 | 2017 | 8969 | 0.010 |
Why?
|
Epidermis | 1 | 2003 | 527 | 0.010 |
Why?
|
Pain, Postoperative | 1 | 2010 | 1638 | 0.010 |
Why?
|
Musculoskeletal Diseases | 1 | 2006 | 581 | 0.010 |
Why?
|
Protein Subunits | 1 | 2003 | 960 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2013 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2006 | 1269 | 0.010 |
Why?
|
Risk Assessment | 2 | 2012 | 23320 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2007 | 1052 | 0.010 |
Why?
|
Infant | 2 | 2014 | 35070 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6294 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2005 | 1402 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21821 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2007 | 21719 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17400 | 0.010 |
Why?
|
Skin Diseases | 1 | 2006 | 1065 | 0.010 |
Why?
|
Obesity | 1 | 2019 | 12705 | 0.010 |
Why?
|
Peptides | 1 | 2008 | 4392 | 0.010 |
Why?
|
Mice | 2 | 2017 | 81045 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23387 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2006 | 4664 | 0.010 |
Why?
|
Cell Movement | 1 | 2003 | 5212 | 0.010 |
Why?
|